definiens: Baseline " and .sho ~ d .. be defined .. by a Jce .. acCo ~ din·g .to .what · · would hi ; a. pr ~ tic31 : and acceptable medicated ~~Et : te . ; C. = . ~Caticasj~ " . rui;d i ~ s:~q~~d .1 : l~ a, fix·e < i or stratffi.ed p~~.ter fo~ ... ~~ .p~~.~t, .,~?l : m~ ; . J?:;~·.~~tbi~~.~_tt ; : ! ~~i?P .. : ! ~.?ti0R:.::~.¥§h:)9-~~~ ~~At . I~~i.9 ~ nJI.I. : : s.~o~!4 ~ eg : ' : ~eg fr.9 m '' ' eac~ patient ; and this sh()I, lldbe·a · fIx~~·or sti.atified parameter.fof.all patient groups ; ? Plaque Tissue·from clinicru sitc(s ) as described··in the·study desigri iri ~ ludmg necessary IRB review and appmva1 ; .and setUp " logistics · for .Sample co.1lectioil··and shipping [COMPANY] to provide > -Merck will iso / al.e Total·.RNA.:from FoXHollow··:Samph!s and provide . to . FoxHollow an RNA QC Report Qn ' h " quillItyand quantiiYofT ala ] RNA i101atedwItjUn f6W ; ( 4j weeks of receipt of .the · J ~ t < Sample : providcl .. bY : FoxHoilow ; ·, : Merck·win iequest.addltionBl S ~ ples.:if .. any fail . $ ~p)e:, . QC . · · jn t4~ ~~,'?~9i·,that . · ~~~pfe.~ · .ec)Ill~ .. · i·~ : ~v~ .. ~ peri~.cf~)f time l~·nger trum foui · y.;eek.s~~¥~n:~~. ~Hl·.pi_oYisl(~:·~A · QG ~ep{J.r ( gn : a inqnthl } ' ~~aS~~ ·